Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Meningeal Carcinomatosis 1Glioma 1

Interventions

Specimen Handling 191Magnetic Resonance Spectroscopy 141Biopsy 102pembrolizumab 85Carboplatin 79Cisplatin 71Nivolumab 64Paclitaxel 52Radiotherapy 51Gemcitabine 51Cyclophosphamide 48Dexamethasone 47durvalumab 39Radiation 39atezolizumab 38Pemetrexed 38olaparib 34Rituximab 34venetoclax 33Etoposide 33Lenalidomide 32Doxorubicin 32Bevacizumab 32X-Rays 30Prednisone 30Docetaxel 30Disulfides 28Ipilimumab 27Immunoglobulin G 27Fluorouracil 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × azeliragon × 30 days × Clear all
NCT06724926 2026-05-18

Concurrent Azeliragon With Craniospinal Irradiation

NYU Langone Health

Phase 1 Active not recruiting
21 enrolled
CNS

Glioma, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡